{"org_id": "T000058587", "org_name_cn": "海南双成药业股份有限公司", "org_short_name_cn": "双成药业", "org_name_en": "Hainan Shuangcheng Pharmaceuticals Co.,Ltd.", "org_short_name_en": "SC Pharmaceuticals", "main_operation_business": "化学合成多肽药品的研发、生产和销售。", "operating_scope": "　　注射剂、胶囊剂、片剂、颗粒剂、原料药的研究、开发、生产、销售;化工产品(专营除外)、普通机械设备的生产销售;药品研发项目的咨询和转让;自有房屋租赁;转让、出租自有专利、非专利技术及商标。", "district_encode": "460105", "org_cn_introduction": "海南双成药业股份有限公司的主营业务是化学合成多肽药品的研发、生产和销售。主要产品有基泰（品名）注射用胸腺法新、注射用左卡尼汀、注射用肌苷、注射用盐酸克林霉素、注射用维生素B6、注射用泮托拉唑钠、注射用法莫替丁、注射用阿奇霉素、注射用生长抑素、注射用环磷腺苷。公司现为国家高新技术企业，主导产品“基泰”药品质量和适应症与原研参比制剂一致，并已获得原研药注册地意大利药品管理局颁发的注射用胸腺法新（基泰）上市许可证，质量层次已达到和原研药同等的标准。报告期内该产品销量的市场占有率约为14%，位居同类产品前列。", "legal_representative": "王成栋", "general_manager": "李建明", "secretary": "于晓风", "established_date": 958924800000, "reg_asset": 412000000.0, "staff_num": 413, "telephone": "86-898-68592978", "postcode": "570314", "fax": "86-898-68592978", "email": "yuxiaofeng@shuangchengmed.com;lifen@shuangchengmed.com", "org_website": "www.shuangchengmed.com", "reg_address_cn": "海南省海口市秀英区兴国路16号", "reg_address_en": "", "office_address_cn": "海南省海口市秀英区兴国路16号", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1344355200000, "provincial_name": "海南省", "actual_controller": "王成栋 (34.37%)，王荧璞 (15.76%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "王成栋", "executives_nums": 12, "actual_issue_vol": 30000000.0, "issue_price": 20.0, "actual_rc_net_amt": 549619719.0, "pe_after_issuing": 35.09, "online_success_rate_of_issue": 1.18112988, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}